XML 72 R57.htm IDEA: XBRL DOCUMENT v3.25.2
FAIR VALUE MEASUREMENTS - Narrative (Details)
6 Months Ended
Jun. 30, 2025
USD ($)
Jun. 30, 2024
USD ($)
Mar. 31, 2025
USD ($)
Dec. 31, 2024
USD ($)
Mar. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]            
Contingent consideration $ 275,408,000 $ 277,921,000 $ 290,498,000 $ 282,212,000 $ 294,260,000 $ 288,657,000
Contingent consideration liability, measurement input       0.90    
Business Combination, Contingent Consideration, Liability, Current       $ 19,700,000    
Business Combination, Contingent Consideration, Liability, Noncurrent       262,500,000    
Venture capital investment fund            
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]            
Investment owned, at fair value 7,400,000     $ 7,500,000    
Committed capital 18,000,000          
Committed capital callable $ 10,100,000          
Product development and other milestone-based payments | Weighted average | Measurement Input, Probability of Success            
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]            
Contingent consideration liability, measurement input 0.90          
Product development and other milestone-based payments | Weighted average | Measurement Input, Present-value Factor            
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]            
Contingent consideration liability, measurement input 0.059     0.062    
Foreign exchange forward            
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]            
Derivative, notional amount $ 50,800,000     $ 44,200,000    
Derivative, fair value 0     0    
Gain (Loss) on derivative instruments, net, pretax 0 $ 0        
Thrive, Ashion and OmicEra | Fair value            
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]            
Contingent consideration       $ 282,200,000    
Resolution Bioscience acquisition adjustments | Fair value            
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]            
Contingent consideration $ 275,400,000